BioCentury | Mar 18, 2020
Politics, Policy & Law

Bay Area labs pare down to essentials following shelter-in-place directives

...SPARKGlobal, an expansion of the SPARK translational science program she founded at Stanford. She co-founded Mitoconix Bio Ltd....
BioCentury | Jan 19, 2018
Strategy

After amyloid

...discovery work,” said Bingham. The DDF participated in a $20 million series A round for Mitoconix Bio Ltd....
...NASDAQ:DNLI), South San Francisco, Calif. IFM Therapeutics LLC, Boston, Mass. Johns Hopkins University, Baltimore, Md. Mitoconix Bio Ltd....
...2017) Winnie Pong, Staff Writer Alector LLC Alzheimer's Drug Discovery Foundation (ADDF) Biogen Inc. Denali Therapeutics Inc. IFM Therapeutics LLC Johns Hopkins University Mitoconix Bio Ltd. National...
BioCentury | Jul 6, 2017
Financial News

Mitoconix raises $20M in series A

...On June 27, neurodegenerative company Mitoconix Bio Ltd. (Jerusalem, Israel) raised $20 million in a series A round...
...has an exclusive, worldwide license to MTC-1203 from Stanford University . Mitoconix Bio Ltd. , Jerusalem, Israel Mary Romeo Mitoconix Bio Ltd. OrbiMed Stanford...
BioCentury | Jun 27, 2017
Financial News

Mitoconix's series A round brings in $20M

...Neurodegenerative company Mitoconix Bio Ltd. (Jerusalem, Israel) said it raised $20 million in a series A round led...
...worldwide license to MTC-1203 from Stanford (see BioCentury Innovations, Jan. 16, 2014) . Mary Romeo Johnson & Johnson Mitoconix Bio Ltd. OrbiMed...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...University of Oxford , Cambridge, University College London and The Institute of Cancer Research . Mitoconix Bio Ltd....
...GmbH, Dortmund, Germany Ludwig Maximilians University of Munich, Munich, Germany Mission Therapeutics Ltd., Cambridge, U.K. Mitoconix Bio Ltd....
...Pharmaceuticals Inc. Iterum Therapeutics Ltd. Kymab Group Ltd. Lead Discovery Center GmbH Ludwig Maximilians University of Munich Metabrain Research Mission Therapeutics Ltd. Mitoconix Bio Ltd. Nicox...
BioCentury | Apr 28, 2017
Finance

Hatching VC incubators

...has invested in mitochondria and autophagy -- two emerging areas of translational biology -- through Mitoconix Bio Ltd....
...San Diego, Calif. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. MBcure Ltd., Ness Ziona, Israel Mitoconix Bio Ltd....
BioCentury | Nov 30, 2016
Distillery Techniques

Biomarkers

...disease progression and monitor treatment response in Huntington’s disease (HD) LICENSING STATUS: Patented; licensed to Mitoconix Bio Ltd....
...7, 2016 doi:10.1084/jem.20160776 CONTACT: Daria Mochly-Rosen, Stanford University School of Medicine, Stanford, Calif. email: mochly@stanford.edu Esme Gaisford Mitoconix Bio Ltd. Stanford...
Items per page:
1 - 7 of 7
BioCentury | Mar 18, 2020
Politics, Policy & Law

Bay Area labs pare down to essentials following shelter-in-place directives

...SPARKGlobal, an expansion of the SPARK translational science program she founded at Stanford. She co-founded Mitoconix Bio Ltd....
BioCentury | Jan 19, 2018
Strategy

After amyloid

...discovery work,” said Bingham. The DDF participated in a $20 million series A round for Mitoconix Bio Ltd....
...NASDAQ:DNLI), South San Francisco, Calif. IFM Therapeutics LLC, Boston, Mass. Johns Hopkins University, Baltimore, Md. Mitoconix Bio Ltd....
...2017) Winnie Pong, Staff Writer Alector LLC Alzheimer's Drug Discovery Foundation (ADDF) Biogen Inc. Denali Therapeutics Inc. IFM Therapeutics LLC Johns Hopkins University Mitoconix Bio Ltd. National...
BioCentury | Jul 6, 2017
Financial News

Mitoconix raises $20M in series A

...On June 27, neurodegenerative company Mitoconix Bio Ltd. (Jerusalem, Israel) raised $20 million in a series A round...
...has an exclusive, worldwide license to MTC-1203 from Stanford University . Mitoconix Bio Ltd. , Jerusalem, Israel Mary Romeo Mitoconix Bio Ltd. OrbiMed Stanford...
BioCentury | Jun 27, 2017
Financial News

Mitoconix's series A round brings in $20M

...Neurodegenerative company Mitoconix Bio Ltd. (Jerusalem, Israel) said it raised $20 million in a series A round led...
...worldwide license to MTC-1203 from Stanford (see BioCentury Innovations, Jan. 16, 2014) . Mary Romeo Johnson & Johnson Mitoconix Bio Ltd. OrbiMed...
BioCentury | May 25, 2017
Finance

Europe’s translational springtime

...University of Oxford , Cambridge, University College London and The Institute of Cancer Research . Mitoconix Bio Ltd....
...GmbH, Dortmund, Germany Ludwig Maximilians University of Munich, Munich, Germany Mission Therapeutics Ltd., Cambridge, U.K. Mitoconix Bio Ltd....
...Pharmaceuticals Inc. Iterum Therapeutics Ltd. Kymab Group Ltd. Lead Discovery Center GmbH Ludwig Maximilians University of Munich Metabrain Research Mission Therapeutics Ltd. Mitoconix Bio Ltd. Nicox...
BioCentury | Apr 28, 2017
Finance

Hatching VC incubators

...has invested in mitochondria and autophagy -- two emerging areas of translational biology -- through Mitoconix Bio Ltd....
...San Diego, Calif. Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. MBcure Ltd., Ness Ziona, Israel Mitoconix Bio Ltd....
BioCentury | Nov 30, 2016
Distillery Techniques

Biomarkers

...disease progression and monitor treatment response in Huntington’s disease (HD) LICENSING STATUS: Patented; licensed to Mitoconix Bio Ltd....
...7, 2016 doi:10.1084/jem.20160776 CONTACT: Daria Mochly-Rosen, Stanford University School of Medicine, Stanford, Calif. email: mochly@stanford.edu Esme Gaisford Mitoconix Bio Ltd. Stanford...
Items per page:
1 - 7 of 7